日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Global Challenges in the Provision of Theranostic Services the International Atomic Energy Agency (IAEA) Perspective

诊疗服务提供的全球挑战：国际原子能机构（IAEA）的视角

期刊:World Journal of Nuclear Medicine
影响因子:0.9
doi:10.1055/s-0045-1807251
Brink, Anita; Cerci, Juliano J; Giammarile, Francesco; Yurystovskyi, Danylo; Korde, Aruna; Estrada-Lobato, Enrique; Mikhail-Lette, Miriam; Pellet, Olivier; Macapinlac, Homer A; Paez, Diana
发表日期：2025
文献求助 收藏

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

异基因CD19特异性CAR-NK细胞治疗CD19+ B细胞肿瘤的安全性、有效性和疗效决定因素：一项1/2期试验

期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-023-02785-8
David Marin # ，Ye Li # ，Rafet Basar # ，Hind Rafei # ，May Daher # ，Jinzhuang Dou ，Vakul Mohanty ，Merve Dede ，Yago Nieto ，Nadima Uprety ，Sunil Acharya ，Enli Liu ，Jeffrey Wilson ，Pinaki Banerjee ，Homer A Macapinlac ，Christina Ganesh ，Peter F Thall ，Roland Bassett ，Mariam Ammari ，Sheetal Rao ，Kai Cao ，Mayra Shanley ，Mecit Kaplan ，Chitra Hosing ，Partow Kebriaei ，Loretta J Nastoupil ，Christopher R Flowers ，Sadie Mae Moseley ，Paul Lin ，Sonny Ang ，Uday R Popat ，Muzaffar H Qazilbash ，Richard E Champlin ，Ken Chen ，Elizabeth J Shpall ，Katayoun Rezvani
细胞生物学
CD19
肿瘤
B细胞
免疫/内分泌
肿瘤免疫
CAR-NK
发表日期：2024
文献求助 收藏

Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis

通过氟代脱氧葡萄糖摄取分析评估选择性RET抑制剂在RET阳性癌症中的疗效

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics14171886
Kairemo, Kalevi; Macapinlac, Homer A; Gouda, Mohammed; Subbiah, Vivek
肿瘤
肿瘤免疫
RET
发表日期：2024
文献求助 收藏

Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors

解读肿瘤反应：氟-18-d-葡萄糖摄取在评估酪氨酸激酶抑制剂靶向治疗中的作用

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm13113269
Kairemo, Kalevi; Gouda, Mohamed; Chuang, Hubert H; Macapinlac, Homer A; Subbiah, Vivek
信号转导
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Sodium fluoride (Na(18)F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors

氟化钠（Na(18)F）PET实体瘤反应标准（NAFCIST）：骨肿瘤反应评估框架

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.101575
Kairemo, K; Gouda, M A; Buschhorn, L; Wahida, A; Macapinlac, H A; Anderson, P M; Subbiah, V
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant

自体干细胞移植前复发或难治性大B细胞淋巴瘤伴残留病灶的正电子发射断层扫描衍生指标

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.18441
Cherng, Hua-Jay J; Xu, Guofan; Feng, Lei; Steiner, Raphael; Fayad, Luis; Strati, Paolo; Nair, Ranjit; Nastoupil, Loretta J; Lee, Hun Ju; Neelapu, Sattva S; Flowers, Christopher R; Rodriguez, Maria; Wang, Michael; Hagemeister, Fredrick; Pinnix, Chelsea C; Ramdial, Jeremy; Srour, Samer; Nieto, Yago; Rezvani, Katayoun; Champlin, Richard; Kebriaei, Partow; Westin, Jason; Macapinlac, Homer A; Shpall, Elizabeth; Ahmed, Sairah
B细胞
发育与干细胞
淋巴瘤
干细胞
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

(18)F-Fluciclovine versus PSMA PET Imaging in Primary Tumor Detection during Initial Staging of High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis

（18）F-氟西洛文与PSMA PET显像在初次分期高危前列腺癌中原发肿瘤检测中的比较：系统评价和荟萃分析

期刊:Radiology-Imaging Cancer
影响因子:6.3
doi:10.1148/rycan.210091
Yadav, Divya; Hwang, Hyunsoo; Qiao, Wei; Upadhyay, Rituraj; Chapin, Brian F; Tang, Chad; Aparicio, Ana; Lopez-Olivo, Maria A; Kang, Stella K; Macapinlac, Homer A; Bathala, Tharakeswara K; Surasi, Devaki Shilpa
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

A Retrospective Comparative Study of Sodium Fluoride Na(18)F-PET/CT and (68)Ga-PSMA-11 PET/CT in the Bone Metastases of Prostate Cancer Using a Volumetric 3-D Radiomic Analysis

回顾性比较氟化钠Na(18)F-PET/CT和(68)Ga-PSMA-11 PET/CT在前列腺癌骨转移中的应用：基于三维容积放射组学分析

期刊:Life-Basel
影响因子:3.4
doi:10.3390/life12121977
Kairemo, Kalevi; Kangasmäki, Aki; Kappadath, Srinivasan Cheenu; Joensuu, Timo; Macapinlac, Homer A
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma

一项关于复发或难治性弥漫性大B细胞淋巴瘤患者在首个挽救性化疗周期内早期PET/CT扫描的前瞻性研究

期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.1080/10428194.2021.1971223
Cherng, Hua-Jay J; Chuang, Hubert H; Steiner, Raphael; Fayad, Luis; Strati, Paolo; Nair, Ranjit; Hagemeister, Fredrick; Nastoupil, Loretta J; Lee, Hun Ju; Neelapu, Sattva S; Flowers, Christopher R; Samaniego, Felipe; Rodriguez, Maria; Macapinlac, Homer A; Feng, Lei; Westin, Jason
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2022
文献求助 收藏

Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma

基于病灶的放射组学特征在治疗前 18F-FDG PET 中预测淋巴瘤对伊布替尼的治疗反应

期刊:
影响因子:
doi:10.1097/RLU.0000000000004060
Jimenez, Jorge E; Dai, Dong; Xu, Guofan; Zhao, Ruiyang; Li, Tengfei; Pan, Tinsu; Wang, Linghua; Lin, Yingyan; Wang, Zhangyang; Jaffray, David; Hazle, John D; Macapinlac, Homer A; Wu, Jia; Lu, Yang
淋巴瘤
发表日期：2022
文献求助 收藏